CA2028897C - Stent and catheter for the introduction of the stent - Google Patents
Stent and catheter for the introduction of the stentInfo
- Publication number
- CA2028897C CA2028897C CA002028897A CA2028897A CA2028897C CA 2028897 C CA2028897 C CA 2028897C CA 002028897 A CA002028897 A CA 002028897A CA 2028897 A CA2028897 A CA 2028897A CA 2028897 C CA2028897 C CA 2028897C
- Authority
- CA
- Canada
- Prior art keywords
- stent
- balloon
- catheter
- fact
- celsius
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/92—Method or apparatus for preparing or treating prosthetic
- Y10S623/921—Blood vessel
Abstract
A stent which is a hollow, cylindrical structure made of a synthetic substance which becomes plastic and malleable in a temperature range from 45 to 75°
Celsius. The stent is brought to the desired site, for example a stenosed section of an artery, by means of a heatable balloon catheter. The stent is heated at the site to be treated and whilst in the plastic state is expanded through dilatation of a balloon. After being cooled to body temperature the expanded stent retains the form achieved. The body fluids bring about complete biodegradation of the implanted stent.
Celsius. The stent is brought to the desired site, for example a stenosed section of an artery, by means of a heatable balloon catheter. The stent is heated at the site to be treated and whilst in the plastic state is expanded through dilatation of a balloon. After being cooled to body temperature the expanded stent retains the form achieved. The body fluids bring about complete biodegradation of the implanted stent.
Description
This discovery concerns a stent for angioplasty, and also a balloon catheter for the lntroduction of the stent.
Stents and more speclflcally lntravascular stents for angloplasty have largely proved useful ln medlcal practice for the preventlon of occluslons or re-stenosls after translumlnal angloplasty. A known stent conslsts of a cartrldge-shaped lattlce made of stalnless steel. The stent, whlch measures 1.6 or 3 mm ln clrcumferences, is attached to a folded balloon catheter and ls brought to the desired site of the blood vessel percutaneously. The stent ls wldened to a diameter of about 3 mm by dilatlng the balloon catheter. The inserted and flxed stent ls left ln the vessel and as a rule becomes covered wlth newly formed lntlma. The artlcle by Jullo C. Plamaz ln the ~ournal Radlology, July 1988, 150:
1263-1269 deals wlth the state of the art in respect of thls technlque.
The ob~ectlve behlnd the dlscovery was to produce a stent of the klnd described which would be even more safe and simple to use but which nevertheless could be manufactured at a lower cost.
The present lnventlon provldes a stent, more speclfically intravascular stent for angioplasty, which can be used percutaneously attached to the balloon of a balloon catheter and which, for its fixation, can be widened through dilatatlon of the balloon, sald stent made out of a materlal whlch has a melting point or a softening range in the range from 45 to 75 Celslus.
The present lnvention also provides an lntravascular stent, adapted for attachment to a balloon of a balloon 1 - ~,L
B ~ 64680-580 catheter, the stent comprlslng a hollow cyllndrlcal structure wlth a length of about 2 to 10 cm made of a materlal havlng a meltlng polnt or a softenlng range ln the range from 45 to 75 Celslus.
The dlscovered stent ls pushed on to the balloon of the balloon catheter at room temperature and ls comparatlvely rlgld and stlff here. The stent can be flxed on to the catheter by sllghtly dllatlng the balloon. Once the stent has been pushed forwards to the deslred slte, for example ln a stenosed sectlon of an artery, lt ls heated through a heatlng faclllty arranged ln the catheter, untll lt can be wldened radlally through dllatatlon of the balloon. The stent - la -D , 64680- 580 D ~
is widened until it sits closely up against the inner wall of the vessel with slight pressure. The heating of the catheter is now stopped, whereupon the stent changes into the solid state comparatively rapidly and retains the dilated form here. In the implanted state the wall-thickness of the stent is less than in its original state so that it is somewhat more flexible.
The stent can therefore adapt to the course of the vessel, within certain limits, in the implanted state.
The discovered stent can be made of a synthetic substance which is presumably better tolerated than metal. Here the inside of the stent can be completely smooth, which reduces the danger of thrombosis.
The discovered stent is particularly suitable for coronary and peripheral angioplasty, but other applications are also conceivable. For example, the discovered stent would be suitable for use whenever it is a question of keeping a passageway permanently or temporarily open. Examples of such passageways are the cystic duct and the urethra.
The stent can be manufactured, for example through extrusion, in a great variety of lengths and also external and internal diameters. A stent of the most suitable dimensions can thus be supplied in every case.
A stent with smaller external - and internal diameters is chosen for the treatment of a coronary artery for example, than for the treatment of a peripheral artery. Similarly, a comparatively short stent is generally used for the treatment of a curved section of vessel.
Following further development of the discovery, the stent is made of a material which is completely biodegradable in body fluids. Aliphatic polyester materials are particularly suitable for this and more specifically materials made of poly (e-caprolactone).
The biological degradation of these synthetic substances is known. Such substances are already used in medicine for the fixation of prostheses and as capsules for the controlled delivery of drugs. The rate of degradation of the material used to manufacture the discovered stent is roughly such that it is completely or largely dissolved within about 2 to 6 months. Since the stent is no longer present at the treated site after a comparatively short period of time, in the case of treatment for a stenosis the risk of thrombosis is less than with a permanently indwelling stent.
A model specimen of the discovery is explained in more detail on the basis of the following drawings:
Fig. 1 shows a perspective view of a stent, as per the discovery, Figs. 2a and 2b show the front end of a balloon catheter with a stent, as per the discovery, before and after dilatation, and Figs. 3a and 3b show diagrammatically a section through a vessel with the stent inserted before and after dilatation.
The stent shown in Figure 1 is a hollow cylindrical structure with a length C of, for example, 2 to 10 cm. For the treatment of a coronary artery the internal diameter B would be 1.0 0.005 mm for example, and the external diameter A 1.6 mm. For the treatment of a peripheral artery the internal diameter B would be 2.0 mm for example, and the external diameter A 3.0 mm. The stent 1 can be manufactured by extrusion. A synthetic substance which melts or which changes into the plastic state through gradual softening in the temperature range from 45 to 75 -202~897 Celsius is suitable as the manufacturing material.
Aliphatic polyesters and in particular poly (E-caprolactone) are a suitable material. Also suitable are polymers which are solid below a temperature of 45 Celsius and which change into a non-crystalline state at least above a temperature of about 70 Celsius.
Suitable polymers are polycaprolactones, polyurethanes and polyamides.
Out of these polymers, those which are biodegradable in body fluids are particularly suitable.
Poly (E-caprolactone) is particularly suitable here, the in vivo degradation of which has been described in the Journal of Applied Polymer Sciences, Vol. 26, 3779-3787 (1981).
A heatable balloon catheter 3 is used in order to bring the stent 1 to the desired treatment site. This catheter has a shaft 2, with three lumina, one lumen 2a being used for the passage of a guidewire.
A salt solution circulates in the other two lumina 2b and 2c, this flowing into and out of the internal space of the balloon 3 through openings which are not shown here. The salt solution is heated and conveyed by a heating - and pump - facility arranged at the proximal end of the shaft 2. Balloon catheters which are heated in the usual known way electrically, with high frequency or micro-waves, could also be used here however.
In order to fix the stent 1 on to the balloon catheter it is pushed on to the folded balloon from the distal end. In many cases the stent 1 is fixed sufficiently to prevent displacement in a longitudinal direction through the fact that its inside la rubs against the cutside 3a of the balloon 3. In other cases the pressure is increased slightly in the balloon 3. As shown in Fig. 2a, the length of the balloon 3 is selected in such a way that this is somewhat longer than the length C of the stent 1. The entire internal surface la of the stent 1 thus lies up against the external surface 3a of the balloon. When the balloon catheter is not yet heated the stent 1 is comparatively rigid and stiff and is not expanded, even when there is comparatively high pressure in the balloon 3.
The catheter, with the stent 1 placed on it, is introduced in the usual known way. For the treatment of a stenosis the catheter is introduced percutaneously with the aid of a guidewire, which is not shown here.
The position of the stent 1 can be monitored radiographically, for example using know marking strips 4.
once the stent 1 has been brought to the desired site with the balloon catheter, the balloon 3 is heated and the stent 1 is brought to a temperature at which plastic expansion becomes possible through dilatation of the balloon 3. For the treatment of a coronary artery, for example, the internal diameter is increased to 2.7 mm and the external diameter to 3.0 mm. In the case of a peripheral artery the internal diameter of the dilated stent is 5.4 mm for example, and the external diameter is 6.0 mm. The wall-thickness of the dilated stent 1' is considerably smaller than that of the original stent 1, as may be seen from Figs. 2a and 2b.
The stent 1 is dilated until its outer surface lies up against the inside of the vessel with slight pressure. This is shown in diagram form in Figs. 3a and 3b. In this case the vessel 5, for example, is a stenosed section of artery 5.
Once the stent 1' is fixed in the vessel the 2û28897 heating of the catheter is stopped, and the temperature of the stent 1' then falls to body temperature, once again assuming the solid state here. The pressure in the balloon 3 is then reduced and the catheter is removed from the vessel in the usual known way.
If the stent 1' is made of poly (E-caprolactone), then auto-catalytic degradation takes place through hydrolytic outer cleavage and it is broken down completely in about 2 to 6 months.
Stents and more speclflcally lntravascular stents for angloplasty have largely proved useful ln medlcal practice for the preventlon of occluslons or re-stenosls after translumlnal angloplasty. A known stent conslsts of a cartrldge-shaped lattlce made of stalnless steel. The stent, whlch measures 1.6 or 3 mm ln clrcumferences, is attached to a folded balloon catheter and ls brought to the desired site of the blood vessel percutaneously. The stent ls wldened to a diameter of about 3 mm by dilatlng the balloon catheter. The inserted and flxed stent ls left ln the vessel and as a rule becomes covered wlth newly formed lntlma. The artlcle by Jullo C. Plamaz ln the ~ournal Radlology, July 1988, 150:
1263-1269 deals wlth the state of the art in respect of thls technlque.
The ob~ectlve behlnd the dlscovery was to produce a stent of the klnd described which would be even more safe and simple to use but which nevertheless could be manufactured at a lower cost.
The present lnventlon provldes a stent, more speclfically intravascular stent for angioplasty, which can be used percutaneously attached to the balloon of a balloon catheter and which, for its fixation, can be widened through dilatatlon of the balloon, sald stent made out of a materlal whlch has a melting point or a softening range in the range from 45 to 75 Celslus.
The present lnvention also provides an lntravascular stent, adapted for attachment to a balloon of a balloon 1 - ~,L
B ~ 64680-580 catheter, the stent comprlslng a hollow cyllndrlcal structure wlth a length of about 2 to 10 cm made of a materlal havlng a meltlng polnt or a softenlng range ln the range from 45 to 75 Celslus.
The dlscovered stent ls pushed on to the balloon of the balloon catheter at room temperature and ls comparatlvely rlgld and stlff here. The stent can be flxed on to the catheter by sllghtly dllatlng the balloon. Once the stent has been pushed forwards to the deslred slte, for example ln a stenosed sectlon of an artery, lt ls heated through a heatlng faclllty arranged ln the catheter, untll lt can be wldened radlally through dllatatlon of the balloon. The stent - la -D , 64680- 580 D ~
is widened until it sits closely up against the inner wall of the vessel with slight pressure. The heating of the catheter is now stopped, whereupon the stent changes into the solid state comparatively rapidly and retains the dilated form here. In the implanted state the wall-thickness of the stent is less than in its original state so that it is somewhat more flexible.
The stent can therefore adapt to the course of the vessel, within certain limits, in the implanted state.
The discovered stent can be made of a synthetic substance which is presumably better tolerated than metal. Here the inside of the stent can be completely smooth, which reduces the danger of thrombosis.
The discovered stent is particularly suitable for coronary and peripheral angioplasty, but other applications are also conceivable. For example, the discovered stent would be suitable for use whenever it is a question of keeping a passageway permanently or temporarily open. Examples of such passageways are the cystic duct and the urethra.
The stent can be manufactured, for example through extrusion, in a great variety of lengths and also external and internal diameters. A stent of the most suitable dimensions can thus be supplied in every case.
A stent with smaller external - and internal diameters is chosen for the treatment of a coronary artery for example, than for the treatment of a peripheral artery. Similarly, a comparatively short stent is generally used for the treatment of a curved section of vessel.
Following further development of the discovery, the stent is made of a material which is completely biodegradable in body fluids. Aliphatic polyester materials are particularly suitable for this and more specifically materials made of poly (e-caprolactone).
The biological degradation of these synthetic substances is known. Such substances are already used in medicine for the fixation of prostheses and as capsules for the controlled delivery of drugs. The rate of degradation of the material used to manufacture the discovered stent is roughly such that it is completely or largely dissolved within about 2 to 6 months. Since the stent is no longer present at the treated site after a comparatively short period of time, in the case of treatment for a stenosis the risk of thrombosis is less than with a permanently indwelling stent.
A model specimen of the discovery is explained in more detail on the basis of the following drawings:
Fig. 1 shows a perspective view of a stent, as per the discovery, Figs. 2a and 2b show the front end of a balloon catheter with a stent, as per the discovery, before and after dilatation, and Figs. 3a and 3b show diagrammatically a section through a vessel with the stent inserted before and after dilatation.
The stent shown in Figure 1 is a hollow cylindrical structure with a length C of, for example, 2 to 10 cm. For the treatment of a coronary artery the internal diameter B would be 1.0 0.005 mm for example, and the external diameter A 1.6 mm. For the treatment of a peripheral artery the internal diameter B would be 2.0 mm for example, and the external diameter A 3.0 mm. The stent 1 can be manufactured by extrusion. A synthetic substance which melts or which changes into the plastic state through gradual softening in the temperature range from 45 to 75 -202~897 Celsius is suitable as the manufacturing material.
Aliphatic polyesters and in particular poly (E-caprolactone) are a suitable material. Also suitable are polymers which are solid below a temperature of 45 Celsius and which change into a non-crystalline state at least above a temperature of about 70 Celsius.
Suitable polymers are polycaprolactones, polyurethanes and polyamides.
Out of these polymers, those which are biodegradable in body fluids are particularly suitable.
Poly (E-caprolactone) is particularly suitable here, the in vivo degradation of which has been described in the Journal of Applied Polymer Sciences, Vol. 26, 3779-3787 (1981).
A heatable balloon catheter 3 is used in order to bring the stent 1 to the desired treatment site. This catheter has a shaft 2, with three lumina, one lumen 2a being used for the passage of a guidewire.
A salt solution circulates in the other two lumina 2b and 2c, this flowing into and out of the internal space of the balloon 3 through openings which are not shown here. The salt solution is heated and conveyed by a heating - and pump - facility arranged at the proximal end of the shaft 2. Balloon catheters which are heated in the usual known way electrically, with high frequency or micro-waves, could also be used here however.
In order to fix the stent 1 on to the balloon catheter it is pushed on to the folded balloon from the distal end. In many cases the stent 1 is fixed sufficiently to prevent displacement in a longitudinal direction through the fact that its inside la rubs against the cutside 3a of the balloon 3. In other cases the pressure is increased slightly in the balloon 3. As shown in Fig. 2a, the length of the balloon 3 is selected in such a way that this is somewhat longer than the length C of the stent 1. The entire internal surface la of the stent 1 thus lies up against the external surface 3a of the balloon. When the balloon catheter is not yet heated the stent 1 is comparatively rigid and stiff and is not expanded, even when there is comparatively high pressure in the balloon 3.
The catheter, with the stent 1 placed on it, is introduced in the usual known way. For the treatment of a stenosis the catheter is introduced percutaneously with the aid of a guidewire, which is not shown here.
The position of the stent 1 can be monitored radiographically, for example using know marking strips 4.
once the stent 1 has been brought to the desired site with the balloon catheter, the balloon 3 is heated and the stent 1 is brought to a temperature at which plastic expansion becomes possible through dilatation of the balloon 3. For the treatment of a coronary artery, for example, the internal diameter is increased to 2.7 mm and the external diameter to 3.0 mm. In the case of a peripheral artery the internal diameter of the dilated stent is 5.4 mm for example, and the external diameter is 6.0 mm. The wall-thickness of the dilated stent 1' is considerably smaller than that of the original stent 1, as may be seen from Figs. 2a and 2b.
The stent 1 is dilated until its outer surface lies up against the inside of the vessel with slight pressure. This is shown in diagram form in Figs. 3a and 3b. In this case the vessel 5, for example, is a stenosed section of artery 5.
Once the stent 1' is fixed in the vessel the 2û28897 heating of the catheter is stopped, and the temperature of the stent 1' then falls to body temperature, once again assuming the solid state here. The pressure in the balloon 3 is then reduced and the catheter is removed from the vessel in the usual known way.
If the stent 1' is made of poly (E-caprolactone), then auto-catalytic degradation takes place through hydrolytic outer cleavage and it is broken down completely in about 2 to 6 months.
Claims (10)
1. Stent, more specifically intravascular stent for angioplasty, which can be used percutaneously attached to the balloon of a balloon catheter and which, for its fixation, can be widened through dilatation of the balloon, said stent made out of a material which has a melting point or a softening range in the range from 45 to 75° Celsius.
2. Stent as claimed in claim 1, characterized by the fact that the material of which it is made is biodegradable in body fluids.
3. Stent as claimed in claim 2, characterized by the fact that the material of which it is made is a polymer.
4. Stent as claimed in claim 3, characterized by the fact that the material of which it is made is an aliphatic polyester.
5. Stent as claimed in claim 4, characterized by the fact that the material of which it is made is polycaprolactone.
6. Stent as claimed in claim 4, characterized by the fact that the material of which it is made is poly (E-caprolactone).
7. Stent as claimed in any one of claims 1 to 6, characterized by the fact that it is a hollow cylindrical structure.
8. An intravascular stent, adapted for attachment to a balloon of a balloon catheter, the stent comprising a hollow cylindrical structure with a length of about 2 to 10 cm made of a material having a melting point or a softening range in the range from 45 to 75° Celsius.
9. The stent of claim 8 comprising an aliphatic polyester.
10. The stent of claim 8 comprising poly (E-caprolactone).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH394689 | 1989-11-01 | ||
CH3946/89 | 1989-11-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2028897A1 CA2028897A1 (en) | 1991-05-02 |
CA2028897C true CA2028897C (en) | 1996-06-25 |
Family
ID=4266886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002028897A Expired - Fee Related CA2028897C (en) | 1989-11-01 | 1990-10-30 | Stent and catheter for the introduction of the stent |
Country Status (12)
Country | Link |
---|---|
US (1) | US5147385A (en) |
EP (1) | EP0428479B1 (en) |
JP (1) | JPH03155869A (en) |
AT (1) | ATE114233T1 (en) |
AU (1) | AU640422B2 (en) |
CA (1) | CA2028897C (en) |
DE (2) | DE9014845U1 (en) |
DK (1) | DK0428479T3 (en) |
ES (1) | ES2063325T3 (en) |
FI (1) | FI905338A0 (en) |
IE (1) | IE61207B1 (en) |
NO (1) | NO179700C (en) |
Families Citing this family (216)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5575815A (en) * | 1988-08-24 | 1996-11-19 | Endoluminal Therapeutics, Inc. | Local polymeric gel therapy |
US5843156A (en) | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
US5749915A (en) * | 1988-08-24 | 1998-05-12 | Focal, Inc. | Polymeric endoluminal paving process |
US5328471A (en) * | 1990-02-26 | 1994-07-12 | Endoluminal Therapeutics, Inc. | Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens |
WO1990001969A1 (en) * | 1988-08-24 | 1990-03-08 | Slepian Marvin J | Biodegradable polymeric endoluminal sealing |
US5571169A (en) * | 1993-06-07 | 1996-11-05 | Endovascular Instruments, Inc. | Anti-stenotic method and product for occluded and partially occluded arteries |
US5622188A (en) * | 1989-08-18 | 1997-04-22 | Endovascular Instruments, Inc. | Method of restoring reduced or absent blood flow capacity in an artery |
US5242399A (en) * | 1990-04-25 | 1993-09-07 | Advanced Cardiovascular Systems, Inc. | Method and system for stent delivery |
US5624392A (en) | 1990-05-11 | 1997-04-29 | Saab; Mark A. | Heat transfer catheters and methods of making and using same |
US5190540A (en) * | 1990-06-08 | 1993-03-02 | Cardiovascular & Interventional Research Consultants, Inc. | Thermal balloon angioplasty |
CA2082410C (en) * | 1991-03-08 | 2003-09-23 | Hideo Tamai | Luminal stent, holding structure therefor and device for attaching luminal stent |
USRE38653E1 (en) | 1991-03-08 | 2004-11-16 | Kabushikikaisha Igaki Iryo Sekkei | Luminal stent, holding structure therefor and device for attaching luminal stent |
US5195969A (en) | 1991-04-26 | 1993-03-23 | Boston Scientific Corporation | Co-extruded medical balloons and catheter using such balloons |
NL9101159A (en) * | 1991-07-03 | 1993-02-01 | Industrial Res Bv | FORMATTABLE EXPANDABLE RING, CYLINDER OR SLEEVE. |
JP2961287B2 (en) * | 1991-10-18 | 1999-10-12 | グンゼ株式会社 | Biological duct dilator, method for producing the same, and stent |
CA2380683C (en) | 1991-10-28 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
EP0553960B1 (en) * | 1992-01-31 | 1997-08-27 | Advanced Cardiovascular Systems, Inc. | Protective membrane for stent-carrying ballon catheter |
US6277084B1 (en) | 1992-03-31 | 2001-08-21 | Boston Scientific Corporation | Ultrasonic medical device |
JPH07505316A (en) | 1992-03-31 | 1995-06-15 | ボストン サイエンティフィック コーポレーション | medical wire |
US6623516B2 (en) * | 1992-08-13 | 2003-09-23 | Mark A. Saab | Method for changing the temperature of a selected body region |
JP3739411B2 (en) * | 1992-09-08 | 2006-01-25 | 敬二 伊垣 | Vascular stent, manufacturing method thereof, and vascular stent device |
US5630840A (en) | 1993-01-19 | 1997-05-20 | Schneider (Usa) Inc | Clad composite stent |
US5486208A (en) * | 1993-02-10 | 1996-01-23 | Ginsburg; Robert | Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification |
US5837003A (en) * | 1993-02-10 | 1998-11-17 | Radiant Medical, Inc. | Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification |
US6033383A (en) * | 1996-12-19 | 2000-03-07 | Ginsburg; Robert | Temperature regulating catheter and methods |
US6849083B2 (en) | 1993-02-10 | 2005-02-01 | Radiant Medical, Inc. | Method and apparatus for controlling a patients's body temperature by in situ blood temperature modification |
US6620188B1 (en) | 1998-08-24 | 2003-09-16 | Radiant Medical, Inc. | Methods and apparatus for regional and whole body temperature modification |
US6110168A (en) * | 1993-02-10 | 2000-08-29 | Radiant Medical, Inc. | Method and apparatus for controlling a patient's body temperature by in situ blood temperature modifications |
US5474563A (en) * | 1993-03-25 | 1995-12-12 | Myler; Richard | Cardiovascular stent and retrieval apparatus |
US5643309A (en) * | 1993-03-25 | 1997-07-01 | Myler; Richard | Cardiovascular stent and retrieval apparatus |
EP0696185B1 (en) * | 1993-04-28 | 1998-08-12 | Focal, Inc. | Apparatus, product and use related to intraluminal photothermoforming |
US5716410A (en) * | 1993-04-30 | 1998-02-10 | Scimed Life Systems, Inc. | Temporary stent and method of use |
US5456667A (en) * | 1993-05-20 | 1995-10-10 | Advanced Cardiovascular Systems, Inc. | Temporary stenting catheter with one-piece expandable segment |
WO1995003010A1 (en) * | 1993-07-23 | 1995-02-02 | Cook Incorporated | A flexible stent having a pattern formed from a sheet of material |
US5618298A (en) * | 1993-10-23 | 1997-04-08 | Simon; Michael | Vascular prosthesis made of resorbable material |
US5545209A (en) | 1993-09-30 | 1996-08-13 | Texas Petrodet, Inc. | Controlled deployment of a medical device |
US6896842B1 (en) | 1993-10-01 | 2005-05-24 | Boston Scientific Corporation | Medical device balloons containing thermoplastic elastomers |
JP2703510B2 (en) | 1993-12-28 | 1998-01-26 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | Expandable stent and method of manufacturing the same |
US6102845A (en) * | 1994-02-07 | 2000-08-15 | Baxter International Inc. | Ventricular assist device with minimal blood contacting surfaces |
US5817100A (en) * | 1994-02-07 | 1998-10-06 | Kabushikikaisya Igaki Iryo Sekkei | Stent device and stent supplying system |
CA2184056C (en) * | 1994-03-01 | 2007-09-11 | Bruce S. Hamilton | Asymmetric dilatation balloon |
US5453090A (en) * | 1994-03-01 | 1995-09-26 | Cordis Corporation | Method of stent delivery through an elongate softenable sheath |
NL9400519A (en) * | 1994-03-31 | 1995-11-01 | Rijksuniversiteit | Intravascular polymeric stent. |
US5921957A (en) * | 1994-07-12 | 1999-07-13 | Scimed Life Systems, Inc. | Intravascular dilation catheter |
US5578149A (en) * | 1995-05-31 | 1996-11-26 | Global Therapeutics, Inc. | Radially expandable stent |
US5591230A (en) * | 1994-09-07 | 1997-01-07 | Global Therapeutics, Inc. | Radially expandable stent |
US5649977A (en) * | 1994-09-22 | 1997-07-22 | Advanced Cardiovascular Systems, Inc. | Metal reinforced polymer stent |
AU700717B2 (en) * | 1994-10-20 | 1999-01-14 | Intra Therapeutics, Inc. | Cystoscope delivery system |
US5674277A (en) * | 1994-12-23 | 1997-10-07 | Willy Rusch Ag | Stent for placement in a body tube |
DE9420877U1 (en) * | 1994-12-29 | 1995-02-16 | Freiburghaus Andreas U | Body for tubular passages |
US5609598A (en) * | 1994-12-30 | 1997-03-11 | Vnus Medical Technologies, Inc. | Method and apparatus for minimally invasive treatment of chronic venous insufficiency |
US6981986B1 (en) | 1995-03-01 | 2006-01-03 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US6818014B2 (en) * | 1995-03-01 | 2004-11-16 | Scimed Life Systems, Inc. | Longitudinally flexible expandable stent |
US6896696B2 (en) | 1998-11-20 | 2005-05-24 | Scimed Life Systems, Inc. | Flexible and expandable stent |
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
DE69622231T2 (en) | 1995-03-01 | 2002-12-05 | Scimed Life Systems Inc | LENGTHFLEXIBLE AND EXPANDABLE STENT |
US5749851A (en) | 1995-03-02 | 1998-05-12 | Scimed Life Systems, Inc. | Stent installation method using balloon catheter having stepped compliance curve |
US5807398A (en) * | 1995-04-28 | 1998-09-15 | Shaknovich; Alexander | Shuttle stent delivery catheter |
FR2733682B1 (en) * | 1995-05-04 | 1997-10-31 | Dibie Alain | ENDOPROSTHESIS FOR THE TREATMENT OF STENOSIS ON BIFURCATIONS OF BLOOD VESSELS AND LAYING EQUIPMENT THEREFOR |
US5591199A (en) * | 1995-06-07 | 1997-01-07 | Porter; Christopher H. | Curable fiber composite stent and delivery system |
US5766201A (en) | 1995-06-07 | 1998-06-16 | Boston Scientific Corporation | Expandable catheter |
US5833707A (en) * | 1995-07-05 | 1998-11-10 | Advanced Cardiovascular Systems, Inc. | Removable stent and method of deployment |
FR2733689B1 (en) * | 1995-08-07 | 1997-08-01 | Dibie Alain | SYSTEM FOR THE EXPANSION OF BLOOD VESSELS |
US5669924A (en) * | 1995-10-26 | 1997-09-23 | Shaknovich; Alexander | Y-shuttle stent assembly for bifurcating vessels and method of using the same |
US5788626A (en) | 1995-11-21 | 1998-08-04 | Schneider (Usa) Inc | Method of making a stent-graft covered with expanded polytetrafluoroethylene |
US6579305B1 (en) * | 1995-12-07 | 2003-06-17 | Medtronic Ave, Inc. | Method and apparatus for delivery deployment and retrieval of a stent comprising shape-memory material |
US5690642A (en) | 1996-01-18 | 1997-11-25 | Cook Incorporated | Rapid exchange stent delivery balloon catheter |
CA2192520A1 (en) | 1996-03-05 | 1997-09-05 | Ian M. Penn | Expandable stent and method for delivery of same |
EP1477133B9 (en) * | 1996-03-05 | 2007-11-21 | Evysio Medical Devices Ulc | Expandable stent |
US6796997B1 (en) | 1996-03-05 | 2004-09-28 | Evysio Medical Devices Ulc | Expandable stent |
US6235053B1 (en) | 1998-02-02 | 2001-05-22 | G. David Jang | Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors |
US6241760B1 (en) | 1996-04-26 | 2001-06-05 | G. David Jang | Intravascular stent |
US20040106985A1 (en) | 1996-04-26 | 2004-06-03 | Jang G. David | Intravascular stent |
JP4636634B2 (en) | 1996-04-26 | 2011-02-23 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Intravascular stent |
US5670161A (en) * | 1996-05-28 | 1997-09-23 | Healy; Kevin E. | Biodegradable stent |
US5800516A (en) * | 1996-08-08 | 1998-09-01 | Cordis Corporation | Deployable and retrievable shape memory stent/tube and method |
US5941895A (en) * | 1996-09-04 | 1999-08-24 | Hemodynamics, Inc. | Cardiovascular stent and retrieval apparatus |
US7749585B2 (en) | 1996-10-08 | 2010-07-06 | Alan Zamore | Reduced profile medical balloon element |
US5843119A (en) * | 1996-10-23 | 1998-12-01 | United States Surgical Corporation | Apparatus and method for dilatation of a body lumen and delivery of a prothesis therein |
US6599316B2 (en) | 1996-11-04 | 2003-07-29 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US7341598B2 (en) | 1999-01-13 | 2008-03-11 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US6325826B1 (en) | 1998-01-14 | 2001-12-04 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US8211167B2 (en) | 1999-12-06 | 2012-07-03 | Boston Scientific Scimed, Inc. | Method of using a catheter with attached flexible side sheath |
US6419625B1 (en) | 1997-01-03 | 2002-07-16 | Robin G. Smith | Methods and devices for ex vivo irradiation of autologous coronary bypass conduit |
US6019777A (en) | 1997-04-21 | 2000-02-01 | Advanced Cardiovascular Systems, Inc. | Catheter and method for a stent delivery system |
WO1998051238A1 (en) | 1997-05-14 | 1998-11-19 | Novo Rps Ulc | Expandable stent and method for production of same |
ATE286687T1 (en) * | 1997-07-17 | 2005-01-15 | Schneider Europ Gmbh | STENT AND PRODUCTION METHOD THEREOF |
US7753950B2 (en) | 1997-08-13 | 2010-07-13 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US5989207A (en) * | 1997-11-03 | 1999-11-23 | Hughes; Boyd R. | Double swirl stent |
US5957975A (en) * | 1997-12-15 | 1999-09-28 | The Cleveland Clinic Foundation | Stent having a programmed pattern of in vivo degradation |
US5962007A (en) * | 1997-12-19 | 1999-10-05 | Indigo Medical, Inc. | Use of a multi-component coil medical construct |
US6001117A (en) * | 1998-03-19 | 1999-12-14 | Indigo Medical, Inc. | Bellows medical construct and apparatus and method for using same |
US6126684A (en) | 1998-04-21 | 2000-10-03 | The Regents Of The University Of California | Indwelling heat exchange catheter and method of using same |
US6419643B1 (en) | 1998-04-21 | 2002-07-16 | Alsius Corporation | Central venous catheter with heat exchange properties |
US6589271B1 (en) | 1998-04-21 | 2003-07-08 | Alsius Corporations | Indwelling heat exchange catheter |
US6338727B1 (en) | 1998-08-13 | 2002-01-15 | Alsius Corporation | Indwelling heat exchange catheter and method of using same |
US6458150B1 (en) | 1999-02-19 | 2002-10-01 | Alsius Corporation | Method and apparatus for patient temperature control |
US6716236B1 (en) | 1998-04-21 | 2004-04-06 | Alsius Corporation | Intravascular catheter with heat exchange element having inner inflation element and methods of use |
US6368304B1 (en) | 1999-02-19 | 2002-04-09 | Alsius Corporation | Central venous catheter with heat exchange membrane |
US8128595B2 (en) | 1998-04-21 | 2012-03-06 | Zoll Circulation, Inc. | Method for a central venous line catheter having a temperature control system |
US6461380B1 (en) | 1998-07-28 | 2002-10-08 | Advanced Cardiovascular Systems, Inc. | Stent configuration |
CN1183881C (en) | 1998-07-31 | 2005-01-12 | 诺维公司 | Small vessel expandable stent and method for prodn. of same |
US6450990B1 (en) | 1998-08-13 | 2002-09-17 | Alsius Corporation | Catheter with multiple heating/cooling fibers employing fiber spreading features |
US6673098B1 (en) * | 1998-08-24 | 2004-01-06 | Radiant Medical, Inc. | Disposable cassette for intravascular heat exchange catheter |
US6620189B1 (en) | 2000-02-28 | 2003-09-16 | Radiant Medical, Inc. | Method and system for control of a patient's body temperature by way of a transluminally insertable heat exchange catheter |
US20050147690A1 (en) * | 1998-09-25 | 2005-07-07 | Masters David B. | Biocompatible protein particles, particle devices and methods thereof |
US7662409B2 (en) * | 1998-09-25 | 2010-02-16 | Gel-Del Technologies, Inc. | Protein matrix materials, devices and methods of making and using thereof |
US6001056A (en) * | 1998-11-13 | 1999-12-14 | Baxter International Inc. | Smooth ventricular assist device conduit |
US7655030B2 (en) | 2003-07-18 | 2010-02-02 | Boston Scientific Scimed, Inc. | Catheter balloon systems and methods |
US8257425B2 (en) | 1999-01-13 | 2012-09-04 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US6299599B1 (en) | 1999-02-19 | 2001-10-09 | Alsius Corporation | Dual balloon central venous line catheter temperature control system |
US6582398B1 (en) | 1999-02-19 | 2003-06-24 | Alsius Corporation | Method of managing patient temperature with a heat exchange catheter |
US6405080B1 (en) | 1999-03-11 | 2002-06-11 | Alsius Corporation | Method and system for treating cardiac arrest |
US6165207A (en) * | 1999-05-27 | 2000-12-26 | Alsius Corporation | Method of selectively shaping hollow fibers of heat exchange catheter |
US6287326B1 (en) | 1999-08-02 | 2001-09-11 | Alsius Corporation | Catheter with coiled multi-lumen heat transfer extension |
US6540774B1 (en) | 1999-08-31 | 2003-04-01 | Advanced Cardiovascular Systems, Inc. | Stent design with end rings having enhanced strength and radiopacity |
EP1082946A1 (en) | 1999-09-09 | 2001-03-14 | Grampp, Stephan, Dr. med. | Intraluminal graft with variable internal diameter |
US6447474B1 (en) | 1999-09-15 | 2002-09-10 | Alsius Corporation | Automatic fever abatement system |
US6475235B1 (en) | 1999-11-16 | 2002-11-05 | Iowa-India Investments Company, Limited | Encapsulated stent preform |
US6702849B1 (en) | 1999-12-13 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Method of processing open-celled microcellular polymeric foams with controlled porosity for use as vascular grafts and stent covers |
US6355058B1 (en) | 1999-12-30 | 2002-03-12 | Advanced Cardiovascular Systems, Inc. | Stent with radiopaque coating consisting of particles in a binder |
US6471721B1 (en) | 1999-12-30 | 2002-10-29 | Advanced Cardiovascular Systems, Inc. | Vascular stent having increased radiopacity and method for making same |
US6537311B1 (en) | 1999-12-30 | 2003-03-25 | Advanced Cardiovascular Systems, Inc. | Stent designs for use in peripheral vessels |
US7947059B2 (en) | 2000-03-02 | 2011-05-24 | Boston Scientific Scimed, Inc. | Multilayer medical device |
EP1132060A2 (en) | 2000-03-09 | 2001-09-12 | LPL Systems Inc. | Expandable stent |
US6436132B1 (en) | 2000-03-30 | 2002-08-20 | Advanced Cardiovascular Systems, Inc. | Composite intraluminal prostheses |
US6945989B1 (en) * | 2000-09-18 | 2005-09-20 | Endotex Interventional Systems, Inc. | Apparatus for delivering endoluminal prostheses and methods of making and using them |
US20020193863A1 (en) * | 2000-09-18 | 2002-12-19 | Endotex Interventional Systems, Inc. | Apparatus for delivering endoluminal prosthesis and methods for preparing such apparatus for delivery |
US7766956B2 (en) | 2000-09-22 | 2010-08-03 | Boston Scientific Scimed, Inc. | Intravascular stent and assembly |
US8070792B2 (en) | 2000-09-22 | 2011-12-06 | Boston Scientific Scimed, Inc. | Stent |
US6652574B1 (en) | 2000-09-28 | 2003-11-25 | Vascular Concepts Holdings Limited | Product and process for manufacturing a wire stent coated with a biocompatible fluoropolymer |
US6607553B1 (en) | 2000-11-17 | 2003-08-19 | B. Braun Medical, Inc. | Method for deploying a thermo-mechanically expandable stent |
US6764504B2 (en) * | 2001-01-04 | 2004-07-20 | Scimed Life Systems, Inc. | Combined shaped balloon and stent protector |
WO2002067653A2 (en) | 2001-02-26 | 2002-09-06 | Scimed Life Systems, Inc. | Bifurcated stent and delivery system |
EP1258229A1 (en) | 2001-05-15 | 2002-11-20 | Vascular Technologies, Inc. | Flexible and elastic vascular stents and grafts |
US6863683B2 (en) | 2001-09-19 | 2005-03-08 | Abbott Laboratoris Vascular Entities Limited | Cold-molding process for loading a stent onto a stent delivery system |
US7597775B2 (en) * | 2001-10-30 | 2009-10-06 | Boston Scientific Scimed, Inc. | Green fluoropolymer tube and endovascular prosthesis formed using same |
US6814561B2 (en) * | 2001-10-30 | 2004-11-09 | Scimed Life Systems, Inc. | Apparatus and method for extrusion of thin-walled tubes |
US6572640B1 (en) | 2001-11-21 | 2003-06-03 | Alsius Corporation | Method and apparatus for cardiopulmonary bypass patient temperature control |
US8623393B2 (en) * | 2002-04-29 | 2014-01-07 | Gel-Del Technologies, Inc. | Biomatrix structural containment and fixation systems and methods of use thereof |
US7025777B2 (en) * | 2002-07-31 | 2006-04-11 | Unison Therapeutics, Inc. | Flexible and conformable stent and method of forming same |
EP1539038A2 (en) * | 2002-09-13 | 2005-06-15 | Linvatec Corporation | Drawn expanded stent |
US7976936B2 (en) * | 2002-10-11 | 2011-07-12 | University Of Connecticut | Endoprostheses |
US7091297B2 (en) * | 2002-10-11 | 2006-08-15 | The University Of Connecticut | Shape memory polymers based on semicrystalline thermoplastic polyurethanes bearing nanostructured hard segments |
US7794494B2 (en) * | 2002-10-11 | 2010-09-14 | Boston Scientific Scimed, Inc. | Implantable medical devices |
ATE534704T1 (en) * | 2002-10-11 | 2011-12-15 | Univ Connecticut | CROSS-LINKED POLYCYCLOOCTENE |
US7524914B2 (en) | 2002-10-11 | 2009-04-28 | The University Of Connecticut | Shape memory polymers based on semicrystalline thermoplastic polyurethanes bearing nanostructured hard segments |
AU2003300377B2 (en) * | 2002-10-11 | 2009-04-02 | University Of Connecticut | Blends of amorphous and semicrystalline polymers having shape memory properties |
EP1575451B1 (en) * | 2002-12-19 | 2010-05-05 | Invatec S.p.A | Endolumenal prosthesis |
US7278984B2 (en) | 2002-12-31 | 2007-10-09 | Alsius Corporation | System and method for controlling rate of heat exchange with patient |
US6951675B2 (en) | 2003-01-27 | 2005-10-04 | Scimed Life Systems, Inc. | Multilayer balloon catheter |
US20040260386A1 (en) * | 2003-01-31 | 2004-12-23 | Shalaby Shalaby W. | Absorbable / biodegradable tubular stent and methods of making the same |
US6846323B2 (en) | 2003-05-15 | 2005-01-25 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US8465537B2 (en) * | 2003-06-17 | 2013-06-18 | Gel-Del Technologies, Inc. | Encapsulated or coated stent systems |
WO2005034852A2 (en) * | 2003-08-26 | 2005-04-21 | Gel-Del Technologies, Inc. | Protein biomaterials and biocoacervates and methods of making and using thereof |
EP1691746B1 (en) * | 2003-12-08 | 2015-05-27 | Gel-Del Technologies, Inc. | Mucoadhesive drug delivery devices and methods of making and using thereof |
US7258697B1 (en) | 2003-12-22 | 2007-08-21 | Advanced Cardiovascular Systems, Inc. | Stent with anchors to prevent vulnerable plaque rupture during deployment |
US8007528B2 (en) | 2004-03-17 | 2011-08-30 | Boston Scientific Scimed, Inc. | Bifurcated stent |
JP5054524B2 (en) | 2004-06-08 | 2012-10-24 | アドバンスド ステント テクノロジーズ, インコーポレイテッド | Stent with protruding branch for branch pipe |
US20060025852A1 (en) * | 2004-08-02 | 2006-02-02 | Armstrong Joseph R | Bioabsorbable self-expanding endolumenal devices |
US8043361B2 (en) * | 2004-12-10 | 2011-10-25 | Boston Scientific Scimed, Inc. | Implantable medical devices, and methods of delivering the same |
US9427340B2 (en) | 2004-12-14 | 2016-08-30 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US7947207B2 (en) | 2005-04-12 | 2011-05-24 | Abbott Cardiovascular Systems Inc. | Method for retaining a vascular stent on a catheter |
US7763198B2 (en) | 2005-04-12 | 2010-07-27 | Abbott Cardiovascular Systems Inc. | Method for retaining a vascular stent on a catheter |
US8317855B2 (en) | 2005-05-26 | 2012-11-27 | Boston Scientific Scimed, Inc. | Crimpable and expandable side branch cell |
US8480728B2 (en) | 2005-05-26 | 2013-07-09 | Boston Scientific Scimed, Inc. | Stent side branch deployment initiation geometry |
US8460357B2 (en) * | 2005-05-31 | 2013-06-11 | J.W. Medical Systems Ltd. | In situ stent formation |
US7731741B2 (en) | 2005-09-08 | 2010-06-08 | Boston Scientific Scimed, Inc. | Inflatable bifurcation stent |
US8043366B2 (en) | 2005-09-08 | 2011-10-25 | Boston Scientific Scimed, Inc. | Overlapping stent |
US8038706B2 (en) | 2005-09-08 | 2011-10-18 | Boston Scientific Scimed, Inc. | Crown stent assembly |
US20070106375A1 (en) * | 2005-11-07 | 2007-05-10 | Carlos Vonderwalde | Bifurcated stent assembly |
US20070112418A1 (en) | 2005-11-14 | 2007-05-17 | Boston Scientific Scimed, Inc. | Stent with spiral side-branch support designs |
US8435284B2 (en) | 2005-12-14 | 2013-05-07 | Boston Scientific Scimed, Inc. | Telescoping bifurcated stent |
US8343211B2 (en) | 2005-12-14 | 2013-01-01 | Boston Scientific Scimed, Inc. | Connectors for bifurcated stent |
US7540881B2 (en) | 2005-12-22 | 2009-06-02 | Boston Scientific Scimed, Inc. | Bifurcation stent pattern |
GB2442181B (en) * | 2006-02-03 | 2009-02-18 | Design & Performance Cyprus Lt | Implantable graft assembly and aneurysm treatment |
US7833264B2 (en) | 2006-03-06 | 2010-11-16 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US8298278B2 (en) | 2006-03-07 | 2012-10-30 | Boston Scientific Scimed, Inc. | Bifurcated stent with improvement securement |
US8333000B2 (en) * | 2006-06-19 | 2012-12-18 | Advanced Cardiovascular Systems, Inc. | Methods for improving stent retention on a balloon catheter |
US7922758B2 (en) | 2006-06-23 | 2011-04-12 | Boston Scientific Scimed, Inc. | Nesting twisting hinge points in a bifurcated petal geometry |
US20080033523A1 (en) * | 2006-07-10 | 2008-02-07 | Gale David C | Stent crack reduction |
US7886419B2 (en) | 2006-07-18 | 2011-02-15 | Advanced Cardiovascular Systems, Inc. | Stent crimping apparatus and method |
US8216267B2 (en) | 2006-09-12 | 2012-07-10 | Boston Scientific Scimed, Inc. | Multilayer balloon for bifurcated stent delivery and methods of making and using the same |
US7988720B2 (en) | 2006-09-12 | 2011-08-02 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US7951191B2 (en) | 2006-10-10 | 2011-05-31 | Boston Scientific Scimed, Inc. | Bifurcated stent with entire circumferential petal |
US8206429B2 (en) | 2006-11-02 | 2012-06-26 | Boston Scientific Scimed, Inc. | Adjustable bifurcation catheter incorporating electroactive polymer and methods of making and using the same |
US7842082B2 (en) | 2006-11-16 | 2010-11-30 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US7959668B2 (en) | 2007-01-16 | 2011-06-14 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US8118861B2 (en) | 2007-03-28 | 2012-02-21 | Boston Scientific Scimed, Inc. | Bifurcation stent and balloon assemblies |
US8647376B2 (en) | 2007-03-30 | 2014-02-11 | Boston Scientific Scimed, Inc. | Balloon fold design for deployment of bifurcated stent petal architecture |
US8087923B1 (en) | 2007-05-18 | 2012-01-03 | C. R. Bard, Inc. | Extremely thin-walled ePTFE |
US8216209B2 (en) | 2007-05-31 | 2012-07-10 | Abbott Cardiovascular Systems Inc. | Method and apparatus for delivering an agent to a kidney |
US9149610B2 (en) | 2007-05-31 | 2015-10-06 | Abbott Cardiovascular Systems Inc. | Method and apparatus for improving delivery of an agent to a kidney |
US9364586B2 (en) | 2007-05-31 | 2016-06-14 | Abbott Cardiovascular Systems Inc. | Method and apparatus for improving delivery of an agent to a kidney |
US9144509B2 (en) | 2007-05-31 | 2015-09-29 | Abbott Cardiovascular Systems Inc. | Method and apparatus for delivering an agent to a kidney |
EP2124855A4 (en) * | 2007-06-22 | 2010-06-09 | Icon Medical Corp | Heatable delivery device |
US8486134B2 (en) | 2007-08-01 | 2013-07-16 | Boston Scientific Scimed, Inc. | Bifurcation treatment system and methods |
US7959669B2 (en) | 2007-09-12 | 2011-06-14 | Boston Scientific Scimed, Inc. | Bifurcated stent with open ended side branch support |
US7833266B2 (en) | 2007-11-28 | 2010-11-16 | Boston Scientific Scimed, Inc. | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
US8277501B2 (en) | 2007-12-21 | 2012-10-02 | Boston Scientific Scimed, Inc. | Bi-stable bifurcated stent petal geometry |
WO2009086483A2 (en) * | 2007-12-26 | 2009-07-09 | Gel-Del Technologies, Inc. | Biocompatible protein particles, particle devices and methods thereof |
US8932340B2 (en) | 2008-05-29 | 2015-01-13 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
US8827954B2 (en) | 2008-06-05 | 2014-09-09 | Boston Scientific Scimed, Inc. | Deflatable bifurcated device |
WO2009149405A1 (en) | 2008-06-05 | 2009-12-10 | Boston Scientific Scimed, Inc. | Balloon bifurcated lumen treatment |
KR20110114522A (en) * | 2008-08-28 | 2011-10-19 | 마르코 안토니오 페나 듀크 | Directional expansion of intraluminal devices |
WO2010042049A1 (en) * | 2008-10-10 | 2010-04-15 | Milux Holding S.A. | Composition, method and device for stabilizing implanted hydraulic devices |
WO2010057177A2 (en) | 2008-11-17 | 2010-05-20 | Gel-Del Technologies, Inc. | Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof |
US9526813B2 (en) | 2009-07-13 | 2016-12-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Intraluminal polymeric devices for the treatment of aneurysms |
EP2658484A1 (en) | 2010-12-30 | 2013-11-06 | Boston Scientific Scimed, Inc. | Multi stage opening stent designs |
US8790388B2 (en) | 2011-03-03 | 2014-07-29 | Boston Scientific Scimed, Inc. | Stent with reduced profile |
EP2680797B1 (en) | 2011-03-03 | 2016-10-26 | Boston Scientific Scimed, Inc. | Low strain high strength stent |
US9278023B2 (en) | 2012-12-14 | 2016-03-08 | Zoll Circulation, Inc. | System and method for management of body temperature |
US9277983B2 (en) * | 2013-03-13 | 2016-03-08 | Abbott Cardiovascular Systems Inc. | Drug delivery device for peripheral artery disease |
US9454187B2 (en) | 2014-08-13 | 2016-09-27 | Dell Products L.P. | Bezel for providing improved user experience |
CN106361465B (en) * | 2015-07-17 | 2018-11-13 | 上海微创医疗器械(集团)有限公司 | A kind of manufacturing method of degradable pipe and biodegradable stent |
US10130465B2 (en) | 2016-02-23 | 2018-11-20 | Abbott Cardiovascular Systems Inc. | Bifurcated tubular graft for treating tricuspid regurgitation |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4286341A (en) * | 1979-04-16 | 1981-09-01 | Iowa State University Research Foundation, Inc. | Vascular prosthesis and method of making the same |
US4636195A (en) * | 1982-04-02 | 1987-01-13 | Harvey Wolinsky | Method and apparatus for removing arterial constriction |
US4799479A (en) * | 1984-10-24 | 1989-01-24 | The Beth Israel Hospital Association | Method and apparatus for angioplasty |
US4763653A (en) * | 1985-02-19 | 1988-08-16 | Rockey Arthur G | Medical sleeve |
FR2577807B1 (en) * | 1985-02-22 | 1993-12-03 | Ethnor | ABSORBABLE COMPOSITE SURGICAL MATERIAL, PREPARATION METHOD, RESORBABLE PROSTHESIS MADE FROM SUCH MATERIAL AND USE OF SUCH A PROSTHESIS |
US4652264A (en) * | 1985-04-25 | 1987-03-24 | American Cyanamid Company | Prosthetic tubular article |
US4923470A (en) * | 1985-04-25 | 1990-05-08 | American Cyanamid Company | Prosthetic tubular article made with four chemically distinct fibers |
US4923464A (en) * | 1985-09-03 | 1990-05-08 | Becton, Dickinson And Company | Percutaneously deliverable intravascular reconstruction prosthesis |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4740207A (en) * | 1986-09-10 | 1988-04-26 | Kreamer Jeffry W | Intralumenal graft |
US4795458A (en) * | 1987-07-02 | 1989-01-03 | Regan Barrie F | Stent for use following balloon angioplasty |
US4870966A (en) * | 1988-02-01 | 1989-10-03 | American Cyanamid Company | Bioabsorbable surgical device for treating nerve defects |
US4877030A (en) * | 1988-02-02 | 1989-10-31 | Andreas Beck | Device for the widening of blood vessels |
WO1990001969A1 (en) * | 1988-08-24 | 1990-03-08 | Slepian Marvin J | Biodegradable polymeric endoluminal sealing |
GB2222954B (en) * | 1988-08-31 | 1991-11-13 | Ethicon Inc | Tubular implant and process for the production thereof |
US4955377A (en) * | 1988-10-28 | 1990-09-11 | Lennox Charles D | Device and method for heating tissue in a patient's body |
JPH0321262A (en) * | 1989-06-20 | 1991-01-30 | Olympus Optical Co Ltd | Living body pipe line expanding tool |
JP2920541B2 (en) * | 1989-09-29 | 1999-07-19 | 日本ゼオン株式会社 | Living organ dilator |
JP2995481B2 (en) * | 1989-09-29 | 1999-12-27 | 日本ゼオン株式会社 | catheter |
-
1990
- 1990-10-25 US US07/603,576 patent/US5147385A/en not_active Expired - Lifetime
- 1990-10-26 DE DE9014845U patent/DE9014845U1/de not_active Expired - Lifetime
- 1990-10-29 FI FI905338A patent/FI905338A0/en not_active IP Right Cessation
- 1990-10-30 CA CA002028897A patent/CA2028897C/en not_active Expired - Fee Related
- 1990-10-31 ES ES90810834T patent/ES2063325T3/en not_active Expired - Lifetime
- 1990-10-31 EP EP90810834A patent/EP0428479B1/en not_active Expired - Lifetime
- 1990-10-31 NO NO904717A patent/NO179700C/en not_active IP Right Cessation
- 1990-10-31 IE IE392590A patent/IE61207B1/en not_active IP Right Cessation
- 1990-10-31 DE DE59007761T patent/DE59007761D1/en not_active Expired - Fee Related
- 1990-10-31 DK DK90810834.3T patent/DK0428479T3/en not_active Application Discontinuation
- 1990-10-31 AU AU65741/90A patent/AU640422B2/en not_active Ceased
- 1990-10-31 JP JP2295131A patent/JPH03155869A/en active Pending
- 1990-10-31 AT AT90810834T patent/ATE114233T1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0428479B1 (en) | 1994-11-23 |
IE903925A1 (en) | 1991-05-08 |
EP0428479A1 (en) | 1991-05-22 |
FI905338A0 (en) | 1990-10-29 |
AU640422B2 (en) | 1993-08-26 |
JPH03155869A (en) | 1991-07-03 |
DK0428479T3 (en) | 1995-03-13 |
CA2028897A1 (en) | 1991-05-02 |
NO179700B (en) | 1996-08-26 |
NO904717D0 (en) | 1990-10-31 |
DE59007761D1 (en) | 1995-01-05 |
NO904717L (en) | 1991-05-02 |
ATE114233T1 (en) | 1994-12-15 |
AU6574190A (en) | 1991-05-09 |
IE61207B1 (en) | 1994-10-19 |
US5147385A (en) | 1992-09-15 |
NO179700C (en) | 1996-12-04 |
DE9014845U1 (en) | 1991-01-10 |
ES2063325T3 (en) | 1995-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2028897C (en) | Stent and catheter for the introduction of the stent | |
EP0920843B1 (en) | Drug delivery system | |
US6001117A (en) | Bellows medical construct and apparatus and method for using same | |
US5891108A (en) | Drug delivery stent | |
US7198637B2 (en) | Method and system for stent retention using an adhesive | |
EP1755485B1 (en) | Method and system for stent retention using an adhesive | |
US5342348A (en) | Method and device for treating and enlarging body lumens | |
US6419692B1 (en) | Surface protection method for stents and balloon catheters for drug delivery | |
CA1336755C (en) | Biodegradable polymeric endoluminal sealing process, apparatus and polymeric products for use therein | |
US5593434A (en) | Stent capable of attachment within a body lumen | |
US5551954A (en) | Biodegradable drug delivery vascular stent | |
JPH05509008A (en) | bioabsorbable stent | |
EP0696185A1 (en) | Apparatus and methods for intraluminal photothermoforming | |
US20040215311A1 (en) | Method and system for improving stent retention using stent openings | |
AU686634C (en) | Apparatus and methods for intraluminal photothermoforming |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |